TAK285-Iodo is an analogue of TAK285, in which the trifluoro group is replaced by iodo. TAK-285 is a novel dual erbB protein kinase inhibitor that specifically targets human epidermal growth factor receptor (EGFR) and HER2. TAK-285 is currently being developed by Takeda.
MedKoo Cat#: 407259
Name: TAK285-Iodo
CAS#: Unknown
Chemical Formula: C25H25ClIN5O3
Exact Mass: 605.0691
Molecular Weight: 605.86
Elemental Analysis: C, 49.56; H, 4.16; Cl, 5.85; I, 20.95; N, 11.56; O, 7.92
The following data is based on the product molecular weight 605.86 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
| 5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
| 10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
| 50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
